LexisNexis® Legal News Podcast for March 14, 2011

AstraZeneca pays 37 state $68.5 million for off-label marketing of atypical antipsychotic drug Seroquel, and, the McNeil division of Johnson & Johnson enters a consent decree for violations at 3 manufacturing plants. Hear these and other stories from LexisNexis® Mealey’s™ Publications. Copyright© 2011 LexisNexis, a division of Reed Elsevier Inc. For the latest litigation news headlines, visit www.lexisnexis.com/mealeys or www.lexisnexis.com/community.

Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.

Related posts:

1. LexisNexis® Legal News Podcast for March 11, 2011 The 2nd Circuit reaffirms an antitrust ruling against American Express,...
2. LexisNexis® Legal News Podcast for March 10, 2011 A drug price class is certified against a drug wholesale...
3. LexisNexis® Legal News Podcast for March 9, 2011 The State of Louisiana files suit against BP and others...
4. LexisNexis® Legal News Podcast for March 4, 2011 A Colorado federal judge dismisses SEC claims against a footwear...
5. LexisNexis® Legal News Podcast for March 3, 2011 The FDA has ordered 500 unapproved cough, cold and allergy...